Biomapas
- Company typePrivate
- Founded2004
- HeadquartersKaunas, Lithuania
- Headcount101–250
- GTM typeB2B
- OfferingServices
Biomapas firmographics
Firmographics- Name
- Biomapas
- Legal name
- UAB Biomapas
- Website
- https://biomapas.com
- Company type
- Private
- Founded year
- 2004
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Ownership category
- akta.pro rank
Biomapas industry classification
Industry- Product category
- Pharmaceutical Contract Research Services
- NAICS
- Scientific Research and Development Services (5417)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Clinical CROs (Phase I–IV) (HLAGAAAA)
- akta.pro secondary industries
- Clinical Operations & Monitoring FSP (CRA/CTM/Start-up) (HLAGAOAA), Medical Writing & Clinical Documentation FSP (HLAGAOAC), Regulatory Affairs & Submissions FSP (HLAGAOAD), Quality Assurance, GxP Compliance & Auditing FSP (HLAGAOAE), Medical Affairs, Scientific Communications & HEOR FSP (HLAGAOAG)
Keywords
Where Biomapas is headquartered
LocationHeadquarters
- HQ city
- Kaunas
- HQ country
- Lithuania
- HQ region
- Europe
Offices1 record
Markets served
Biomapas business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Clinical Research Services: Full-service and Functional Service Provision (FSP) clinical research services including site monitoring, data management, patient recruitment, and clinical trial management across Phase I-IV studies.
- Pharmacovigilance Services: Comprehensive PV services including case processing, aggregate reporting, PSMF development, RMP writing, PV system setup, QPPV services, audits, and regulatory intelligence. Provided as standalone or integrated solutions.
- Regulatory Affairs Services: Regulatory strategy, dossier development, marketing authorization applications, lifecycle management, promotional material review, and local regulatory affairs support across EU, EAEU, and CIS regions.
- Medical Information Services: 24/7 medical information contact center, medical writing, content creation, translation and localization services, and integrated PV-MI solutions.
- Quality Assurance Services: Export auditors who identify gaps and provide actionable solutions, GCP training, and inspection readiness training.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Project-based professional services pricing |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels6 records
Biomapas product offering
Product offeringCore offering
Biomapas is a pan-European pharma services provider offering four core service lines — Clinical Research, Regulatory Affairs, Pharmacovigilance, and Medical Information — supported by Quality Assurance. The company delivers these as full-service or Functional Service Provision (FSP) outsourcing models to pharmaceutical and biotech clients across 70+ countries, with deep local expertise in the CEE, CIS, EAEU, and MENA regions.
Product overview
Biomapas is a pan-European pharma services provider offering four core services: Clinical Research, Regulatory Affairs, Pharmacovigilance, and Medical Information, supported by Quality Assurance. The company operates a platform-plus-modules architecture where the four core service lines serve as the foundation, supplemented by specialized modules including PV-MI Integrated Solutions (powered by Nexentria En3), Pharmacovigilance System Set-Up & QPPV, Safety Database (Veeva Vault Safety), Global Case Processing, Medical Monitoring, PSMF Development, RMP Development, EAEU QPPV Services, Local Pharmacovigilance Representation, Literature Screening, Pharmacovigilance Audits, Medical Inquiry Management, Medical Writing, Regulatory Strategy & Gap Analysis, Dossier Development, eCTD Compilation, Lifecycle Management, and training programs like GCP Training and Biomapas Academy. The portfolio also includes specialized outsourcing models (FSP, Affiliate-Based Outsourcing) and niche services (Early Phase Oncology, CSV for PV Systems, M&A Support).
Differentiator
Problem solved
Functional benefit
Products and services
- Clinical Research
Quantifiable outcome
- 150+ Marketing Authorizations obtained through National Procedures
- +2 more outcomes
Companies that use Biomapas
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles3 records
Biomapas technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration4 records
AI capability3 records
Feature3 records
Biomapas partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core.
- Nexentria (En3 Platform)coreBiomapas utilizes Nexentria's En3 platform to power their integrated PV-MI solutions. This technology partnership enables unified pharmacovigilance and medical information workflows, providing global pharma and biotech clients with a single integrated system for case management, reporting, and oversight across 70+ countries.
- Veeva Systems (Vault Safety)coreBiomapas utilizes Veeva Vault Safety as their primary safety database for pharmacovigilance operations, supporting adverse event management, case processing, and regulatory submissions. The platform enables real-time oversight, role-based assignment, and medical review workflows.
- Delta PVcoreOn August 4, 2025, Biomapas announced the acquisition of Delta PV, a trusted pharmacovigilance service provider headquartered in Istanbul, Turkey. This strategic acquisition expands Biomapas' PV capabilities and brings them closer to their goal of building a truly global platform in life sciences services.
Scale indicators6 records
Recent moves7 records
Expansion highlights5 records
Biomapas competitors and assessment
Company assessmentDirect peers
- Ergomed plc: Mid-sized European-headquartered CRO and pharmacovigilance services provider with comparable service mix (clinical research, PV, regulatory) and similar enterprise pharma/biotech client base. The closest direct peer to Biomapas in scale and positioning.
- PrimeVigilance: Specialized pharmacovigilance and regulatory services provider serving pharma and biotech globally. Overlaps heavily with Biomapas' PV, QPPV, and regulatory offerings.
- PharmaLex (Cencora): Regulatory affairs, pharmacovigilance, and quality management consulting firm now part of Cencora/World Courier. Directly competes in RA, PV, and MA lifecycle services.
Broad incumbents
- IQVIA: Largest global CRO with comprehensive clinical, PV, regulatory, and real-world evidence services. Competes with Biomapas on enterprise pharma FSP and full-service awards at a much larger scale.
- ICON plc: Top-tier global CRO offering clinical, laboratory, and post-approval/PV services. Competes for large multi-service outsourcing contracts that overlap with Biomapas' FSP offering.
- Parexel International: Major global CRO with deep PV and regulatory affairs practice; competes for the same enterprise pharma client base across clinical and post-marketing services.
- Syneos Health: Biopharmaceutical services organization offering clinical and commercial services. Overlaps with Biomapas in clinical operations and post-marketing/PV services for large pharma.
- Medpace Holdings: Mid-to-large CRO focused on clinical development for emerging biopharma. Comparable in size segment and competitive set, though narrower in PV/regulatory breadth than Biomapas.
- Worldwide Clinical Trials: Mid-sized global CRO with strong CNS, oncology, and rare disease clinical operations. Comparable mid-tier CRO competitor for Biomapas' biotech client segment.
Emerging players
- Arriello: Specialized regulatory affairs and pharmacovigilance consultancy serving pharma across Europe. Smaller and more focused than Biomapas, but directly comparable service portfolio.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
Biomapas social profiles
Digital presenceBiomapas financial estimates
Financial estimateRevenue estimate
Valuation estimate
Biomapas leadership team
Management profileNumber of profiles
Profiles8 records
Biomapas subsidiaries and ownership
Company hierarchySubsidiaries1 record
Biomapas funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Biomapas M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Biomapas
What does Biomapas do?
Biomapas is a pan-European pharma services provider offering four core service lines — Clinical Research, Regulatory Affairs, Pharmacovigilance, and Medical Information — supported by Quality Assurance. The company delivers these as full-service or Functional Service Provision (FSP) outsourcing models to pharmaceutical and biotech clients across 70+ countries, with deep local expertise in the CEE, CIS, EAEU, and MENA regions.
Is Biomapas a public or private company?
Biomapas is a private company. It is classified as private equity controlled and is currently operating.
When was Biomapas founded?
Biomapas was founded in 2004. It employs 101 to 250 people.
Where is Biomapas based?
Biomapas is headquartered in Kaunas, Lithuania, in the Europe region.
How does Biomapas make money?
Five revenue lines are on record. Clinical Research Services are the primary driver. The others are pharmacovigilance Services, regulatory Affairs Services, medical Information Services and quality Assurance Services.
Who are Biomapas's main competitors?
Direct peers on record are Ergomed plc, PrimeVigilance and PharmaLex (Cencora). Broad incumbents are IQVIA, ICON plc, Parexel International, Syneos Health, Medpace Holdings and Worldwide Clinical Trials. Arriello is listed as an emerging player.
Does Biomapas have an API?
No public API is recorded for Biomapas.
What industry is Biomapas in?
Biomapas's product category is Pharmaceutical Contract Research Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGAOAA, Clinical Operations & Monitoring FSP (CRA/CTM/Start-up). Its NAICS code is 5417 and its SIC code is 8731.